Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab

• Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events.

Detalles Bibliográficos
Autores principales: Wu, Meng, Bennett, Jennifer A., Reid, Pankti, Fleming, Gini F., Kurnit, Katherine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326349/
https://www.ncbi.nlm.nih.gov/pubmed/34368414
http://dx.doi.org/10.1016/j.gore.2021.100837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326349/
https://www.ncbi.nlm.nih.gov/pubmed/34368414
http://dx.doi.org/10.1016/j.gore.2021.100837

Ejemplares similares